Alto Neuroscience vs Cellcolabs
Alto Neuroscience vs Cellcolabs, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and Cellcolabs on 55/100.
Where each one leads
Alto Neuroscience
- agent readiness: 48/100 against 40/100
- domain rating: 44/100 against 37/100
- funding raised: $370M against $15.5M
- LinkedIn following: 24,482 against 6,563
Cellcolabs
- our overall score: 55/100 against 43/100
At a glance
| Measure | Alto Neuroscience | Cellcolabs |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2021 |
| Headquarters | Los Altos, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Alto Neuroscience | Cellcolabs |
|---|---|---|
| Employees | 86 | 79 |
| Total funding | $370M | $15.5M |
| Latest round | Registered Direct Offering | Not published |
| LinkedIn followers | 24,482 | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 55/100 |
| Traction | 59/100 | Not published |
| Community | 13/100 | Not published |
| Search visibility | 35/100 | 2/100 |
| Quality | 45/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | Cellcolabs |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
Alto Neuroscience vs Cellcolabs: common questions
Which is better, Alto Neuroscience or Cellcolabs?
On our 0-100 score Cellcolabs rates higher (55/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and Cellcolabs compare on the numbers?
Alto Neuroscience leads on agent readiness (48/100 against 40/100), domain rating (44/100 against 37/100), funding raised ($370M against $15.5M), LinkedIn following (24,482 against 6,563). Cellcolabs leads on our overall score (55/100 against 43/100).
Read the full Alto Neuroscience review and pricing or the Cellcolabs review and pricing. You can also browse other Alto Neuroscience alternatives we track.